TROVAGENE INC | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

View All

Latest Posts

About This Stock More About This Stock
Premarket Biotech Digest – DMPI Receives Approval, PFE Slapped From FDA
Article By: KKD Healthcare Analytics
Friday, June 23, 2017 9:31 AM EDT
DelMar Pharmaceuticals announced that it has received Institutional Review Board approval to conduct a Phase 3 clinical trial. Pfizer received a setback from the FDA. Roche announced receiving the FDA approval .
In this article: PFE, RHHBY, TROV, QGEN, DMPI, IONS, VTGN, PRTO
Read
Why Ligand Pharmaceuticals Is A Good Long-Term Investment Opportunity
Article By: Arie Goren
Wednesday, April 19, 2017 10:40 AM EDT
Ligand is a fast growing biotech company with a distinctive business model. Investors can participate in the high-promising biotech industry by investing in LGND stock with lower-risk than investing in a typical high-growth biotechnology company.
In this article: LGND Also: TROV, NVAX, CLVS, EXEL
Read
James Altucher's Key To Investing Success
Article By: Casey Research
Monday, November 9, 2015 2:35 PM EDT
James Altucher shares the best investment strategy he's ever learned and how investors can learn from the likes of Warren Buffett, Peter Thiel, Mark Cuban & more. After all, "if you're the smartest person in the room, then you're in the wrong room."
In this article: AMBA, GPRO, IBM, TROV
Read
All Posts

Latest Tweets for $TROV

No tweets yet!

PARTNER HEADLINES